MediciNova Receives a Notice of Intention to Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Europe

Source: Nasdaq GlobeNewswire / 16 Aug 2023 18:00:00   America/Chicago